QuantRx Biomedical Stock Forecast, Price & News

0.00 (0.00 %)
(As of 09/15/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume40,000 shs
Average Volume199,867 shs
Market Capitalization$1.18 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive QTXB News and Ratings via Email

Sign-up to receive the latest news and ratings for QuantRx Biomedical and its competitors with MarketBeat's FREE daily newsletter.

About QuantRx Biomedical

QuantRx Biomedical Corp. engages in developing and commercializing its patented miniform pads (PADs) and PAD based over-the-counter products for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, general catamenial uses, and other medical needs. It also develops and intends to commercialize genomic diagnostics for the laboratory market, based on its lateral flow patents. Its platforms include inSync, UniqueTM, and oriinal equipment manufacturer branded over-the-counter and laboratory testing products. The company was founded on December 5, 1986 and is headquartered in Tualatin, OR.


QuantRx Biomedical Corporation (QTXB)
QuantRx Biomedical Corporation (QTXB)
January 9, 2021 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.13 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.0Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

QuantRx Biomedical (OTCMKTS:QTXB) Frequently Asked Questions

What stocks does MarketBeat like better than QuantRx Biomedical?

Wall Street analysts have given QuantRx Biomedical a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but QuantRx Biomedical wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is QuantRx Biomedical's next earnings date?

QuantRx Biomedical is scheduled to release its next quarterly earnings announcement on Tuesday, November 16th 2021.
View our earnings forecast for QuantRx Biomedical

How has QuantRx Biomedical's stock price been impacted by Coronavirus?

QuantRx Biomedical's stock was trading at $0.0046 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, QTXB stock has increased by 226.1% and is now trading at $0.0150.
View which stocks have been most impacted by COVID-19

Who are QuantRx Biomedical's key executives?

QuantRx Biomedical's management team includes the following people:
  • Shalom Z. Hirschman, Chairman, CEO & Principal Accounting Officer

Who are some of QuantRx Biomedical's key competitors?

What other stocks do shareholders of QuantRx Biomedical own?

What is QuantRx Biomedical's stock symbol?

QuantRx Biomedical trades on the OTCMKTS under the ticker symbol "QTXB."

How do I buy shares of QuantRx Biomedical?

Shares of QTXB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is QuantRx Biomedical's stock price today?

One share of QTXB stock can currently be purchased for approximately $0.02.

How much money does QuantRx Biomedical make?

QuantRx Biomedical has a market capitalization of $1.18 million.

What is QuantRx Biomedical's official website?

The official website for QuantRx Biomedical is www.quantrx.com.

Where are QuantRx Biomedical's headquarters?

QuantRx Biomedical is headquartered at 10190 SW 90TH AVENUE, TUALATIN OR, 97062.

How can I contact QuantRx Biomedical?

QuantRx Biomedical's mailing address is 10190 SW 90TH AVENUE, TUALATIN OR, 97062. The company can be reached via phone at (212) 980-2235.

This page was last updated on 9/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.